Moreover, HIF-1α is over-expressed in about 24–56% of invasive breast cancers [17–21] or even more and has been associated with increased VEGF expression [15, 20], increased angiogenesis [21], higher tumor grade [15, 20], as well as treatment failure and poor prognosis [7, 19]. This evidence concerns the gene HIF1A and neoplasm.